Inventor · disambiguated record
Alan S. Kopin
Also filed as: KOPIN ALAN S
12 granted patents·14 pending applications·115 citations·filing 1992–2025
89Inventor score
Files withTUFTS MEDICAL CENTER9NEW ENGLAND MEDICAL CENTER INC3TUFTS MEDICAL CT INC3NEW ENGLAND MEDICAL CT2AUTTX LLC1
Top patents by PatentIndex Score
26 records- 0187US11254720B2Methods and systems for designing and/or characterizing soluble lipidated ligand agentsTUFTS MEDICAL CENTER·Filed 2019·Granted Feb 22, 2022·2 cites·5 claims
- 0286US5750353AAssay for non-peptide agonists to peptide hormone receptorsNEW ENGLAND MEDICAL CENTER INC·Filed 1995·Granted May 12, 1998·73 cites·12 claims
- 0385US2025179130A1Methods and systems for designing and/or characterizing soluble lipidated ligand agentsTUFTS MEDICAL CENTER·Filed 2024·Application pending·0 cites
- 0484US10233219B2Methods and systems for designing and/or characterizing soluble lipidated ligand agentsTUFTS MEDICAL CENTER·Filed 2014·Granted Mar 19, 2019·4 cites·12 claims
- 0577US12060397B2Soluble lipidated ligand agents for treating eye inflammationTUFTS MEDICAL CENTER·Filed 2021·Granted Aug 13, 2024·0 cites·6 claims
- 0675US9662314B2Compounds and methods for the treatment of muscular disease, and related screening methodsTUFTS MEDICAL CT INC·Filed 2012·Granted May 30, 2017·2 cites·20 claims
- 0775US2024325486A1Methods for treating symptoms of dry eye diseaseTUFTS MEDICAL CENTER·Filed 2024·Application pending·0 cites
- 0874US11197906B2Methods of lowering blink reflex for the treatment of dry eye diseaseTUFTS MEDICAL CENTER·Filed 2017·Granted Dec 14, 2021·2 cites·5 claims
- 0969US12053501B2Methods for treating symptoms of dry eye diseaseTUFTS MEDICAL CENTER·Filed 2021·Granted Aug 6, 2024·0 cites·8 claims
- 1065US11718646B2Bovine adrenal medulla peptide 8-22 compounds and methods of use thereof for treating painTUFTS MEDICAL CENTER·Filed 2020·Granted Aug 8, 2023·0 cites·11 claims
- 1158US10899796B2Compounds and methods for treating painTUFTS MEDICAL CENTER·Filed 2016·Granted Jan 26, 2021·0 cites·13 claims
- 1251US6376198B1Assay for non-peptide agonists to peptide hormone receptorsNEW ENGLAND MEDICAL CENTER INC·Filed 1998·Granted Apr 23, 2002·13 cites·8 claims
- 1350US2025290074A1Targeted treatment of spliceopathy-induced neurological disordersAUTTX LLC·Filed 2025·Application pending·0 cites
- 1449US6566080B1Assay for and uses of peptide hormone receptor agonistsNEW ENGLAND MEDICAL CT·Filed 1998·Granted May 20, 2003·8 cites·13 claims
- 1547US2003191114A1Assay for and uses of peptide hormone receptor agonistsFiled 2003·Application pending·0 cites
- 1646US2021236438A1Compounds and methods for the treatment of autism spectrum disorder and other neurological or psychiatric disordersTUFTS MEDICAL CT INC·Filed 2019·Application pending·0 cites
- 1745US2003180798A1Assay for non-peptide agonists to peptide hormone receptorsFiled 2002·Application pending·0 cites
- 1844US2003087313A1Dose response-based methods for identifying receptors having alterations in signalingFiled 2002·Application pending·0 cites
- 1944US2003148390A1Dose response-based methods for identifying receptors having alterations in signalingFiled 2002·Application pending·0 cites
- 2043US5541071AAssay for identifying antagonists of gastrin and CCK-B receptorsNEW ENGLAND MEDICAL CENTER INC·Filed 1992·Granted Jul 30, 1996·11 cites·5 claims
- 2142US2021228531A1Targeted treatment of autism spectrum disorder and other neurological or psychiatric disordersTUFTS MEDICAL CT INC·Filed 2019·Application pending·0 cites
- 2242US2004049800A1Rapid methods for assessing therapeutic activity using animals expressing constitutively active G protein coupled receptorsFiled 2003·Application pending·0 cites
- 2340US2004214992A1Mutation induced optimization of receptor signal to noise ratioFiled 2002·Application pending·0 cites
- 2439US2002127539A1Assays for identifying receptors having alterations in signalingFiled 2001·Application pending·0 cites
- 2538US2006177438A1Methods of altering absorption of hydrophobic compoundsNEW ENGLAND MEDICAL CT·Filed 2005·Application pending·0 cites
- 2637US2002147170A1Constitutively active, hypersensitive, and nonfunctional recepors as novel therapeutic agentsFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →